Qyuns Therapeutics Co., Ltd. (HKG:2509)

Hong Kong · Delayed Price · Currency is HKD

16.56

-0.18 (-1.08%)

Oct 22, 2026, 3:57 PM HKT

Qyuns Therapeutics Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Millions HKD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 21, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	3,699	4,236	1,639	-	-	-
Market Cap Growth	-44.02%	158.47%	-	-	-	-
Enterprise Value	3,265	4,309	1,494	-	-	-
Last Close Price	16.74	18.78	7.38	-	-	-

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 21, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	5.91	12.11	-	-	-	-
PS Ratio	3.16	4.72	9.70	-	-	-
PB Ratio	3.85	5.61	6.97	-	-	-
P/TBV Ratio	3.77	5.50	6.83	-	-	-
P/FCF Ratio	6.40	9.70	-	-	-	-
P/OCF Ratio	6.23	9.52	-	-	-	-

EV Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 21, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	2.79	4.80	8.84	-	-	-
EV/EBITDA Ratio	4.68	10.74	-	-	-	-
EV/EBIT Ratio	4.93	11.73	-	-	-	-
EV/FCF Ratio	5.66	9.87	-	-	-	-

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 21, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	0.82	0.85	2.39	1.15	0.45	0.41
Debt / EBITDA Ratio	1.12	1.60	-	-	-	-
Debt / FCF Ratio	1.36	1.48	-	-	-	-
Net Debt / Equity Ratio	-0.42	-0.68	-0.13	-0.10	-0.48	-0.47
Net Debt / EBITDA Ratio	-0.58	-1.28	0.09	0.06	1.08	2.12
Net Debt / FCF Ratio	-0.70	-1.18	0.16	0.10	1.30	1.83
Asset Turnover	0.67	0.63	0.18	-	0.01	-
Inventory Turnover	2.41	15.70	18.73	-	-	-
Quick Ratio	1.96	2.11	1.36	1.50	5.06	9.03
Current Ratio	2.29	2.22	1.43	1.66	5.21	9.30
Return on Equity (ROE)	101.58%	68.31%	-133.98%	-108.33%	-45.74%	-
Return on Assets (ROA)	23.84%	15.97%	-24.04%	-35.11%	-19.27%	-
Return on Capital Employed (ROCE)	43.70%	30.10%	-61.80%	-94.60%	-35.50%	-18.00%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 21, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	16.93%	8.26%	-21.79%	-	-	-
FCF Yield	15.62%	10.31%	-12.16%	-	-	-
Buyback Yield / Dilution	-1.28%	-1.94%	-6.70%	-15.67%	-52.95%	-